ZURICH, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering a…
MDM2 degradation demonstrated differentiated biological activity and superior cell killing compared to small molecule inhibition…
Studies provide insight into bifunctional molecular mechanism and first in vivo demonstration of immunomodulatory imide…
Data demonstrates the potential for de novo engineering of novel synthetic cytotoxic effector cells that show significant…
Findings presented today at AACR Annual Meeting detail Calithera discovery of VPS4A inhibitors and their…
CAMBRIDGE, Mass., April 08, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company…
– Data from multiple solid tumor indications confirms that MAGE-A4 is a broadly expressed cancer…
GENEVA, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) — iOnctura SA, a clinical-stage oncology company targeting…
First data presentation on AGEN1571 shows strong adaptive and innate immune responses Preclinical data indicate…
– Late-breaking presentation at AACR demonstrates potential to significantly delay onset of drug resistance to…
Treatment with EOS-448 results in a decrease of TIGIT-positive cells in tumor biopsies, the first…
– ONCR-021 and ONCR-788 demonstrate robust preclinical anti-tumor efficacy following IV-administration – – vRNA Immunotherapy…
– Preclinical data demonstrate the use of gene circuits to improve the therapeutic potential of…
Preclinical data demonstrate that edited iNK cells result in increased persistence, enhanced anti-tumor activity and…
Anti-tumor data from systemic novel TREX1 inhibitors designed to activate the STING pathway selectively in…
Best Responses Include Partial Responses in Certain Patients with Non-Small Cell Lung Cancer, Metastatic Anal…
– ANV419 is very well-tolerated and demonstrates exceptional safety with strong pharmacodynamic effects and excellent…
OSLO, Norway, April 08, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD),…
– New preclinical data presented at AACR Annual Meeting 2022 – – Intravenous exosome candidate…
– Data Highlight Essential Role of GSPT1 in Sustaining Myc-induced Translational Addiction in Solid Tumors…